| # | Drug | Count |
|---|---|---|
| 0 | EMICIZUMAB | 12 |
| 1 | PREDNISONE | 8 |
| 2 | BISOPROLOL FUMARATE | 7 |
| 3 | FUROSEMIDE | 7 |
| 4 | OXACILLIN | 7 |
| 5 | OXACILLIN SODIUM | 7 |
| 6 | LEVOFLOXACIN | 6 |
| 7 | LEVOFLOXACIN IN 5% DEXTROSE | 6 |
| 8 | ROSUVASTATIN | 6 |
| 9 | ACETAMINOPHEN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARSTACIMAB-HNCQ | 2 | 0.0194 |
| 1 | OXACILLIN SODIUM | 7 | 0.0062 |
| 2 | EMICIZUMAB | 12 | 0.0009 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 4 | TAFAMIDIS | 2 | 0.0002 |
| 5 | LEVOFLOXACIN | 6 | 0.0001 |
| 6 | DIMENHYDRINATE | 1 | 0.0001 |
| 7 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 8 | ENTECAVIR | 1 | 0.0001 |
| 9 | MAGNESIUM HYDROXIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 6 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Insulin [EPC] | 2 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Loop Diuretic [EPC] | 7 | 0.0000 |